2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Melanoma
6
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Diarrhea
3
Colitis
3
Carcinoma, Hepatocellular
3
Urogenital Neoplasms
2
Solid Carcinoma
2
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Vomiting
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Non Small Cell Lung Cancer Metastatic
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Nausea
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Interventions
Megestrol Acetate
9
Exercise
6
Standard of Care
4
Blood Specimen Collection
4
Olanzapine
3
Ibuprofen
3
dermcidin
2
anamorelin
2
Resistance Training
2
Physical Therapy Modalities
2
Nutrition Assessment
2
Mirtazapine
2
Melatonin
2
Infliximab
2
Enteral Nutrition
2
Dietary Supplements
2
Diet Therapy
2
Cyproheptadine
2
testosterone enanthate
1
telotristat ethyl
1
remune
1
ostarine
1
olanzapine-fluoxetine combination
1
nabiximols
1
nabilone
1
irinotecan sucrosofate
1
fucoidan
1
clazakizumab
1
bermekimab
1
alkaloid GB18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cachexia
×
Fecal Microbiota Transplantation
×
Clear all
NCT07533227
2026-04-16
FMT-CACH
Changzhou No.2 People's Hospital
Phase 2
Not yet recruiting
66 enrolled